Your browser doesn't support javascript.
loading
A patient-centric modeling framework captures recovery from SARS-CoV-2 infection.
Ruffieux, Hélène; Hanson, Aimee L; Lodge, Samantha; Lawler, Nathan G; Whiley, Luke; Gray, Nicola; Nolan, Tui H; Bergamaschi, Laura; Mescia, Federica; Turner, Lorinda; de Sa, Aloka; Pelly, Victoria S; Kotagiri, Prasanti; Kingston, Nathalie; Bradley, John R; Holmes, Elaine; Wist, Julien; Nicholson, Jeremy K; Lyons, Paul A; Smith, Kenneth G C; Richardson, Sylvia; Bantug, Glenn R; Hess, Christoph.
Afiliación
  • Ruffieux H; MRC Biostatistics Unit, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK. helene.ruffieux@mrc-bsu.cam.ac.uk.
  • Hanson AL; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK.
  • Lodge S; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.
  • Lawler NG; Australian National Phenome Centre, Health Futures Institute, Murdoch University, Perth, Western Australia, Australia.
  • Whiley L; Center for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Perth, Western Australia, Australia.
  • Gray N; Australian National Phenome Centre, Health Futures Institute, Murdoch University, Perth, Western Australia, Australia.
  • Nolan TH; Center for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Perth, Western Australia, Australia.
  • Bergamaschi L; Australian National Phenome Centre, Health Futures Institute, Murdoch University, Perth, Western Australia, Australia.
  • Mescia F; Center for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Perth, Western Australia, Australia.
  • Turner L; Perron Institute for Neurological and Translational Science, Nedlands, Western Australia, Australia.
  • de Sa A; Australian National Phenome Centre, Health Futures Institute, Murdoch University, Perth, Western Australia, Australia.
  • Pelly VS; Center for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Perth, Western Australia, Australia.
  • Kotagiri P; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK.
  • Kingston N; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.
  • Bradley JR; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK.
  • Holmes E; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.
  • Wist J; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK.
  • Nicholson JK; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.
  • Lyons PA; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK.
  • Smith KGC; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.
  • Richardson S; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK.
  • Bantug GR; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.
Nat Immunol ; 24(2): 349-358, 2023 02.
Article en En | MEDLINE | ID: mdl-36717723

Texto completo: 1 Base de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Prognostic_studies Idioma: En Revista: Nat Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2023 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Prognostic_studies Idioma: En Revista: Nat Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2023 Tipo del documento: Article